These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30502686)

  • 1. Synthesis and biological evaluation as antiangiogenic agents of ureas derived from 3'-aminocombretastatin A-4.
    Conesa-Milián L; Falomir E; Murga J; Carda M; Marco JA
    Eur J Med Chem; 2019 Jan; 162():781-792. PubMed ID: 30502686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel multitarget inhibitors with antiangiogenic and immunomodulator properties.
    Conesa-Milián L; Falomir E; Murga J; Carda M; Marco JA
    Eur J Med Chem; 2019 May; 170():87-98. PubMed ID: 30878834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors.
    Machado VA; Peixoto D; Costa R; Froufe HJ; Calhelha RC; Abreu RM; Ferreira IC; Soares R; Queiroz MJ
    Bioorg Med Chem; 2015 Oct; 23(19):6497-509. PubMed ID: 26344591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
    Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
    Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of cyclic derivatives of combretastatin A-4 containing group 14 elements.
    Blasco V; Murga J; Falomir E; Carda M; Royo S; Cuñat AC; Sanz-Cervera JF; Marco JA
    Org Biomol Chem; 2018 Aug; 16(32):5859-5870. PubMed ID: 30070286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
    Eldehna WM; Fares M; Ibrahim HS; Aly MH; Zada S; Ali MM; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA
    Eur J Med Chem; 2015 Jul; 100():89-97. PubMed ID: 26071861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases.
    Thompson AM; Delaney AM; Hamby JM; Schroeder MC; Spoon TA; Crean SM; Showalter HD; Denny WA
    J Med Chem; 2005 Jul; 48(14):4628-53. PubMed ID: 16000000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 2,4-disubstituted-2-thiopyrimidines as VEGFR-2 inhibitors: Design, synthesis, and biological evaluation.
    Abdel-Mohsen HT; Girgis AS; Mahmoud AEE; Ali MM; El Diwani HI
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900089. PubMed ID: 31463965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
    Elsayed NMY; Serya RAT; Tolba MF; Ahmed M; Barakat K; Abou El Ella DA; Abouzid KAM
    Bioorg Chem; 2019 Feb; 82():340-359. PubMed ID: 30428414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity.
    Al-Ansary GH; Nasr T; Taha H; Fayad W; Mahgoub S
    Bioorg Chem; 2021 Feb; 107():104640. PubMed ID: 33485105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-Raf
    Sun S; He Z; Huang M; Wang N; He Z; Kong X; Yao J
    Bioorg Med Chem; 2018 May; 26(9):2381-2391. PubMed ID: 29631788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of N-acyl Derivatives of Aminocombretastatin A-4 and Study of their Interaction with Tubulin and Downregulation of c-Myc.
    Agut R; Falomir E; Murga J; Martín-Beltrán C; Gil-Edo R; Pla A; Carda M; Díaz JF; Josa-Prado F; Marco JA
    Med Chem; 2021; 17(10):1129-1139. PubMed ID: 33222678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimidinylacetamide-based 2-pyridylureas as Angiogenesis Inhibitors: Design, Synthesis and Biological Evaluation.
    Deng YH; Yan ZH; Liu JP; Liu Y; Sun LP
    Arch Med Res; 2017 May; 48(4):333-342. PubMed ID: 28882321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers.
    Zahran SS; Ragab FA; Soliman AM; El-Gazzar MG; Mahmoud WR; Ghorab MM
    Bioorg Chem; 2024 Jul; 148():107411. PubMed ID: 38733747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors.
    Ravez S; Barczyk A; Six P; Cagnon A; Garofalo A; Goossens L; Depreux P
    Eur J Med Chem; 2014 May; 79():369-81. PubMed ID: 24747748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation.
    Wang C; Gao H; Dong J; Zhang Y; Su P; Shi Y; Zhang J
    Bioorg Med Chem; 2014 Jan; 22(1):277-84. PubMed ID: 24315192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents.
    Pla-López A; Castillo R; Cejudo-Marín R; García-Pedrero O; Bakir-Laso M; Falomir E; Carda M
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Combretastatin A-4 and 3'-Aminocombretastatin A-4 derivatives with Aminoacid Containing Pendants and Study of Their Interaction with Tubulin and as Downregulators of the VEGF, hTERT and c-Myc Gene Expression.
    Agut R; Falomir E; Murga J; Martín-Beltrán C; Gil-Edo R; Pla A; Carda M; Marco JA
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32033084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel VEGFR-2 inhibitors. Part II: biphenyl urea incorporated with salicylaldoxime.
    Gao H; Su P; Shi Y; Shen X; Zhang Y; Dong J; Zhang J
    Eur J Med Chem; 2015 Jan; 90():232-40. PubMed ID: 25461323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.